Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Feinberg: IAVI Neutralizing Antibody Consortium |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2017-08-17 |
| Study Made Public: | 2018-09-06 |
Title
Immune response in rabbits to eOD-GT8 60mer, with or without GSK’s AS01B adjuvant
Description
CAVD 679 is a preclinical study in rabbits evaluating repeated dosing of eOD-GT8 60mer protein and AS01 B adjuvant.
Sign in to see full information about this study and to download study data.
Products
AS01B eOD-GT8 60mer Formulation bufferIntegrated data
BAMA
Non-integrated data
No non-integrated data is available for this study.